Top compounds associated with response to DDO


Feature Type Standardized
Nominal ANOVA
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.094 0.01
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC 0.13 0.01
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA MST-312 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA CI-976 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.088 0.01
mRNA AZ628 GDSC1000 pan-cancer AAC 0.12 0.01
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.077 0.02
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.091 0.02
Download CSV